|
2019
|
Invention
|
Powder formulation.
The invention relates to sterile powder compositions suitable for medical us... |
|
2018
|
Invention
|
Powder delivery device.
Provided is a device for the dispensing of powders of the type in which ... |
|
|
Invention
|
High-purity large-scale preparation of stannsoporfin. Large scale (bulk) compositions comprising ... |
|
2017
|
Invention
|
Fibrinogen preparations enriched in fibrinogen with an extended alpha chain. The present inventio... |
|
|
Invention
|
Methods for treating hyperbilirubinemia with stannsoporfin and phototherapy.
Methods of treating... |
|
|
Invention
|
Biodegradable extravascular stent. The present invention relates to extravascular supports. In pa... |
|
2016
|
Invention
|
Recombinant fibrinogen. The present invention relates to nucleotide sequences encoding a fibrinog... |
|
|
Invention
|
Processing blood.
Methods (300), devices, and systems of processing blood are described. The met... |
|
2015
|
Invention
|
Methods for synthesizing metal mesoporphyrins. Embodiments describe methods of synthesizing metal... |
|
2014
|
Invention
|
Administration and monitoring of nitric oxide in ex vivo fluids.
Described are systems and metho... |
|
|
Invention
|
Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation.
Dis... |
|
|
Invention
|
Methods of reducing the risk of mortality associated with a medical treatment.
Disclosed are met... |
|
|
Invention
|
Method and apparatus for generating nitric oxide for medical use. 2 is minimized. One or both of ... |
|
|
Invention
|
Devices and methods for engaging indexed valve and pressurized canister assembly with collar and ... |
|
|
Invention
|
Dosing regimens and methods of treatment using carbon monoxide.
The present invention is directe... |
|
|
Invention
|
Devices and methods for monitoring oxygenation during treatment with delivery of nitric oxide.
T... |
|
|
Invention
|
Powder formulation comprising thrombin and fibrinogen.
The invention relates to sterile powder c... |
|
|
Invention
|
Powder formulation. The invention relates to sterile powder compositions suitable for medical use... |
|
2013
|
Invention
|
Cannula for minimizing dilution of dosing during nitric oxide delivery. The present invention gen... |
|
|
Invention
|
Nitric oxide delivery device. A nitric oxide delivery device including a valve assembly, a contro... |
|
|
Invention
|
Gas delivery device and system. A gas delivery system including a gas delivery device, a control ... |
|
|
Invention
|
Therapeutic gas delivery device |
|
|
Invention
|
System and method of administering a pharmaceutical gas to a patient. A method and system for del... |
|
|
Invention
|
Methods of administering nitric oxide to arterial or arterialized blood. The present invention pr... |
|
|
Invention
|
Breathing apparatus detection and purging. Described are methods for safer nitric oxide delivery,... |
|
2012
|
Invention
|
Methods for treating hyperbilirubinemia with stannsoporfin.
Some embodiments relate to methods o... |
|
|
Invention
|
Methods for treating patients who are candidates for inhaled nitric oxide treatment. Disclosed ar... |
|
|
Invention
|
System for use in administering inhaled nitric oxide gas.
Disclosed are systems for use in admin... |
|
|
Invention
|
Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation. Disc... |
|
|
Invention
|
Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitri... |
|
|
Invention
|
Formulations for wound therapy. The present invention relates to novel formulations comprising a ... |
|
2011
|
Invention
|
Powder delivery device. Provided is a device for the dispensing of powders of the type in which a... |
|
|
Invention
|
Medical powder delivery instrument |
